ACADIA Pharmaceuticals Help Lift Biotech ETFs
September 09, 2019 at 16:55 PM EDT
While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS: ACAD), following the biopharma company’s positive announcement for a phase 3 trail on...